CN106376933A - Brain-invigorating antioxidant health product and applications thereof - Google Patents
Brain-invigorating antioxidant health product and applications thereof Download PDFInfo
- Publication number
- CN106376933A CN106376933A CN201610770493.6A CN201610770493A CN106376933A CN 106376933 A CN106376933 A CN 106376933A CN 201610770493 A CN201610770493 A CN 201610770493A CN 106376933 A CN106376933 A CN 106376933A
- Authority
- CN
- China
- Prior art keywords
- oil
- brain
- health
- care product
- delavayi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 26
- 230000036541 health Effects 0.000 title claims abstract description 23
- 235000019198 oils Nutrition 0.000 claims abstract description 58
- 241000928579 Malania oleifera Species 0.000 claims abstract description 49
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 38
- 241000736199 Paeonia Species 0.000 claims abstract description 31
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 31
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 8
- 241000195493 Cryptophyta Species 0.000 claims abstract description 8
- 235000013376 functional food Nutrition 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 241000847925 Paeonia ostii Species 0.000 claims abstract description 3
- 239000000544 cholinesterase inhibitor Substances 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 31
- 238000000605 extraction Methods 0.000 claims description 22
- 238000005728 strengthening Methods 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000003825 pressing Methods 0.000 claims description 11
- 235000013305 food Nutrition 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 206010039966 Senile dementia Diseases 0.000 claims description 7
- 240000005001 Paeonia suffruticosa Species 0.000 claims description 6
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 230000006866 deterioration Effects 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 241000124495 Paeonia delavayi Species 0.000 claims 6
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 241000196324 Embryophyta Species 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 210000003792 cranial nerve Anatomy 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 230000003925 brain function Effects 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 47
- 240000003693 Docynia delavayi Species 0.000 description 25
- 239000002253 acid Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 5
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 5
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008157 edible vegetable oil Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 229940022698 acetylcholinesterase Drugs 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- -1 DPPH free radical Chemical class 0.000 description 2
- ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000577951 Hydnum Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000221014 Olacaceae Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000002951 street drug Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100001265 toxicological assessment Toxicity 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- C11B1/106—Production of fats or fatty oils from raw materials by extracting using ultra-sounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A brain-invigorating antioxidant health product is composed of the following components in percentage by weight: 60 to 75% of malania oleifera oil, 10 to 20% of peony seed oil, 1 to 5% of natural VE with a purity of 80%, and 5 to 15% of DHA algae oil. The invention also discloses applications of the brain-invigorating antioxidant health product in the preparation of health product for preventing Alzheimer's disease or brain function degradation, acetylcholin esterase inhibitor, and functional food. The peony seed oil is prepared from Shangri-La Yunnan peony and paeonia ostii. The health product has dual health functions of malania oleifera oil and peony seed oil, can improve the activity of cranial nerves and prevent encephalasthenia, can also treat cardiovascular diseases and autoimmune diseases, and can be used as blood nutrient, vitamin F, or plant DHA. The health product has an important health value for people who need the nutrient and health functions.
Description
Technical field
The invention belongs to technical field of health care food is and in particular to a kind of antioxidant functional food and its application.
Background technology
Malania oleifera also known as hedgehog hydnum fruit, mountain paulownia fruit etc., are that Olacaceae Herba Kalimeridis wood belongs to unique Relict Plant, are Chinese the eastern regions of the Yunnan Province
South and the distinctive rareness species in the western karst in osmanthus ground mountain region, are Chinese Second Class Key Protected Plant, it is distributed in the wide of southeastern Yunnan
The Limestone Mountain Areas of the 500-1640m such as south, Funing and West Guangxi, are the important afforestation in karst seeds, are to pass again
The edible oil plant of system, has huge Ecosystem Service and high economic worth.The Malania Oleifera Oil extracting from malania oleifera contains
There is 40%~60% tetracosa carbon -15- olefin(e) acid, be a kind of long-chain monounsaturated fatty acid, because it is from shark brain, cattle earliest
Separate in brain and gain the name, tetracosa carbon -15- olefin(e) acid is brain development, the required nutrient maintaining, to raising cranial nerve
Enliven, prevent cerebral neurastheria from playing a very important role;Cardiovascular and human autoimmune's shortage property disease are also had fairly good
Curative effect.
P. delavayi pattern is gorgeous, and having rare yellow flower in Tree Peony Cultivars is genetic resourceses, is Cultivated tree peonies choosing
Educate the important parental source that yellow flower is new varieties.P. delavayi pattern variation type enriches, and except yellow, (or petal base portion has purple
Speckle) outward, also green, yellow green, orange, pink colour, aubergine, black purple etc., larger black purple in plant part petal base portion
Allochromatic colour fringing, green color stripe etc. in speckle, edge, are the important germ plasm resource cultivating Flower New Variety kind.Additionally, its root bark also has
Have important medical value, its cold in nature, sour-acrid taste, root bark be used for clearing away heat and cooling blood, control haematemesis, hematuria, dysentery, dysmenorrhea etc., also by
Medicinal as Cortex Moutan, central nervous system can be suppressed, have expansion coronary vasodilator, blood pressure lowering, the antibacterial, function such as antiinflammatory, anticoagulation, be
Extract the important source material of different kind organism active substance, there is exploitation prospect.In recent years research display peony seed oil has pole
High nutritive value, is the fabulous raw material that high-grade edible oil and health product produce.In March, 2011 ratifies Paeonia suffruticosa through health ministry
Seed oil, as new resource food, enters edible oil ranks, causes great attention.Through experimental tests Paeonia suffruticosa seed oil content reaches
20%, wherein unsaturated fatty acid content is up to 85%, and-linolenic acid content reaches 35%, is 140 times of olive oil.Alpha-linolenic acid
It is to constitute human body brain cell and histiocytic important component, being that human body is indispensable itself can not synthesize and irreplaceable
Polyunsaturated fatty acid, has the title of " hemotrophic nutrition element ", " vitaminF " and " plant NAOHUANGJIN " again.Therefore, peony seed oil is for I
Excellent edible oil resource in the new food resource of state.
Paeonia suffruticosa does not only have high ornamental value, also considerable medical value.Moutan root bark is used as medicine, and name is said " red
Skin ", Cortex Moutan has and purifies the blood, and the function of promoting blood circulation to remove blood stasis is clinically mainly used in clearing away liver-fire and cool the blood dissipate blood stasis (antiinflammatory, blood pressure lowering).Male
Red seed oil has very high nutritive value, by the toxicological assessment of health ministry, Ministry of Public Health 2011 the 9th
Number bulletin approval peony seed oil as new resource food, be that the edible exploitation of peony seed oil provides Fundamentals of Law.Peony seed oil
It is with peony seeds benevolence as raw material, make through techniques such as squeezing, decolouring, deodorizes, containing substantial amounts of linolenic acid, linoleic acid and oil
The unsaturated fatty acids such as acid.In numerous unsaturated fatty acids, linolenic acid is a kind of polyunsaturated fatty acid of ω -3 series,
It is also a kind of essential fatty acid that human body can not itself synthesize. Oleic acid is then referred to as " safe fats acid ", is effectively reduced gallbladder solid
Deposition on blood vessel for the alcohol, has the effects such as prevention of arterial hardening, particularly important to the health of cardiovascular and cerebrovascular vessel. and linoleic acid is a kind of
ω -6 series polyunsaturated fatty acid, has the suppression synthesis of cholesterol in human body, antioxidation, anticancer, prevention diabetes etc. to make
With.Therefore Paeonia suffruticosa not only has high ornamental value, and its oil resource value and medical value have also obtained widely
Develop and use.Low serious plus pest and disease damage yet with P. delavayi seed-setting rate, so P. delavayi is planted in its natural state
Sub- emergence rate is extremely low, and sexual propagation is difficult.And Seedling Populations rare numbers under natural conditions, human activity interference is as artificially in addition
The reasons such as excavation, tourism development, reclamation of wasteland arable land make its habitat constantly be nibbled, and habitat is seriously damaged, and germ plasm resource is anxious
Reduce sharply few.Therefore study in the urgent need to the protection to P. delavayi wild resource with Application way.P. delavayi is as one
Wild stockss, have and have stronger adaptability to ecological environment, have Morphological Diversity and genetic diversity, asexual multiplication ability
By force, the advantages of efficiency high, it is that the exploitation of P. delavayi provide practical basis.
At present, there are no the diligent valence value of Related Drug, the report of oil resource value of P. delavayi in prior art, more do not have
Have and reasonably develop and useedd, also Malania Oleifera Oil and peony seed oil composition are not had the health care food of collaborative health-care effect
The report of product formula.
Content of the invention
It is an object of the invention to provide a kind of antioxidant functional food is by Malania Oleifera Oil, peony seed oil, purity 80% day
So VE and purity 40%DHA algae oil are formed, and have the synergism of antioxidation and anti-cardiovascular disease.
In order to realize the above-mentioned purpose of the present invention, the invention provides following technical scheme:
Brain-strengthening antioxidant health-care product, by weight percentage this health product are made up of following components:
Malania Oleifera Oil 60%-75%, peony seed oil 10-20%, purity 80% natural VE 1%-5%, purity 40%DHA
Algae oil 5%-15%.
According to described brain-strengthening antioxidant health-care product, wherein Malania Oleifera Oil be 70%-75%, peony seed oil be 20-30%,
Purity 80% natural VE be 1%-3%,.
According to described brain-strengthening antioxidant health-care product, wherein Malania Oleifera Oil be 71.1%, peony seed oil be 17%, purity
80% natural VE is 1.9%, purity 40%DHA algae oil is 10%.
The preparation method of brain-strengthening antioxidant health-care product, the Malania Oleifera Oil in described anti-health product is to be prepared by following methods
And obtain:Take malania oleifera kernel, pulverize, cross 20-40 mesh sieve, high temperature steaming 20-30 minute, by liquid ratio 1:3-5V:V, g:ML adds
Enter edible ethanol, ultrasonic assistant extracts 30-40min, ultrasonic power 120-150W, and ultrasonic temperature is 30-40 DEG C, ultrasonic carry
Take 2-3 time, sucking filtration, merging filtrate, in 40-50 DEG C of concentrating under reduced pressure, remove solvent and obtain Malania Oleifera Oil.
The preparation method of described brain-strengthening antioxidant health-care product, the peony seed oil in described anti-health product is by following sides
Method is prepared:Take P. delavayi seed screen after naturally drying in the shade, shell, being dried, pulverize after cross 60 mesh sieves obtain P. delavayi seed powder,
Carry out supercritical carbon dioxide extraction, extraction conditionss are:Extraction time 60min, 40 DEG C of temperature, pressure 45MPa, CO2 flow
20kg/h;Or take P. delavayi seed powder to carry out cold pressing, 30 DEG C of cold pressing temperature, cold pressing pressure 60MPa, cold pressing time 2h;Or take Yunnan male
Red seed powder carries out surname extraction, and Extraction solvent is petroleum ether, screen size 60 mesh, 70 DEG C of Extracting temperature, and solid-to-liquid ratio is 1:30.
Described brain-strengthening antioxidant health-care product is in the health product preparing anti-senile dementia disease or anti-cerebral functional deterioration disease
Application.
Application in preparing acetylcholinesteraseinhibitors inhibitors for the described brain-strengthening antioxidant health-care product.
Application in preparing functional food for the described brain-strengthening antioxidant health-care product.
According to described brain-strengthening antioxidant health-care product, it is male that Shangri-la Yunnan taken from by the raw material of wherein said peony seed oil
Red.
According to described brain-strengthening antioxidant health-care product, P. delavayi taken from by the raw material of wherein said peony seed oil and Paeonia ostii is male
Red.
Patent and document report with regard to Malania Oleifera Oil are as follows.Invention disclosed patent " a kind of supercritical CO in 20142Liquid
The method that body extracts Malania Oleifera Oil " adopts supercritical extraction Malania Oleifera Oil, but the method high cost, equipment investment are high, uncomfortable
For industrial mass production, and Malania Oleifera Oil viscosity is larger, and many at normal temperatures exist in solid form, therefore, shooting flow
Body abstraction technique is difficult to by Malania Oleifera Oil extraction completely.In addition, also on " Malania Oleifera Oil preparation biodiesel ", " malania oleifera
The Patents report of fruit pulp extraction quintessence oil ", but the patent of health product is prepared with regard to Malania Oleifera Oil and P. delavayi oil compatibility
Have no report.
Compared with prior art, the present invention possesses following excellent benefit:The health product of the present invention have Malania Oleifera Oil and male
Red seed oil double health effect, both can be to improving enlivening, preventing cerebral neurastheria from playing a very important role of cranial nerve, Bulbus Allii
It is rich in nervonic acid, nervonic acid is the unique specific drug treating senile dementia at present in fruit oil.And Malania Oleifera Oil is as the present invention
Main component, in malania oleifera, neural acid content is 25%, is significantly larger than the plant that other contain nervonic acid composition, therefore this
Bright main feature is enriched in nervonic acid, for hypomnesis, does not have enough sleep, and often stays up late, subhealth state that operating pressure is big
Crowd has good relieving mental strain and helping sleep, the effect of memory reinforcing;Middle-aged and elderly people for hypomnesis, cell senescence can improve
Memory, the generation of prevention senile dementia.Additionally since the another one main component P. delavayi oil of the present invention, mainly it is rich in
Linoleic acid plus linolenic acid, energy vessel softening, lacking property disease to cardiovascular and human autoimmune also has goodish curative effect, also
Can be used as the nutrition health-care functions of " hemotrophic nutrition element ", " vitaminF " and " plant NAOHUANGJIN ".To need simultaneously supplement above-mentioned battalion
Support and the crowd of health care has important health value.
The present invention adopts ultrasonic assistant from Malania oleifera to oily extraction, with food grade ethanol for extracting solvent to Bulbus Allii
Fruit seed kernel oil is extracted, and can extract the oils and fatss in Malania oleifera to greatest extent, this extraction process compared with traditional method,
There are oils and fatss and improve extraction efficiency, shorten extraction time it is not necessary to main equipment can complete the extraction of oil, the method sets simultaneously
Standby and reagent input cost is low, simple to operate, onestep extraction, no waste liquor contamination, and residual residue is alternatively arranged as extracting protein, many
The raw material of sugar, is the optimum extracting method comparing the extraction Malania Oleifera Oil confirming after multiple methods at present.
The present invention prepares peony seed oil with P. delavayi Fruit pod and kind skin for raw material, turns waste into wealth, and is that the synthesis of P. delavayi is closed
Reason develops provides Technical Reference, has important protection of resources to the Reasonable Protection of P. delavayi and the utilization of resources of P. delavayi
With environmental conservation meaning.
Brief description
Fig. 1 is P. delavayi seed oil gas chromatogram total ion current figure;
Fig. 2 is the time effect curve figure that DPPH free radical removed by P. delavayi seed oil;
Fig. 3 removes the dose effect curve figure of DPPH free radical for peony seed oil.
Specific embodiment:
Below in conjunction with the accompanying drawings, further illustrate the essentiality content of the present invention with embodiments of the invention, but not with
This is limiting present disclosure.
Embodiment 1:
Malania Oleifera Oil 700g, P. delavayi oil 295g, vitamin e1 0g mix homogeneously, it is heated to 40 DEG C, constant temperature preserves, adopt
Pressed film method prepares soft capsule, soft capsule 2000, every 250mg is obtained altogether, wherein neural acid content is 43.75mg/ grain.
Wherein Malania Oleifera Oil is prepared by following methods:Take malania oleifera kernel, pulverize, cross 20-40 mesh sieve, high temperature steaming
20-30 minute, by liquid ratio 1:3-5V:V, g:ML adds edible ethanol, and ultrasonic assistant extracts 30-40min, ultrasonic power
120-150W, ultrasonic temperature is 30-40 DEG C, supersound extraction 2-3 time, sucking filtration, merging filtrate, in 40-50 DEG C of concentrating under reduced pressure, removes
Solvent obtains Malania Oleifera Oil.
Peony seed oil is prepared by following methods:Take P. delavayi seed screen after naturally drying in the shade, shell, being dried, powder
Cross 60 mesh sieves after broken and obtain P. delavayi seed powder, carry out supercritical carbon dioxide extraction, extraction conditionss are:Extraction time 60min, temperature
40 DEG C, pressure 45MPa, CO2Flow 20kg/h;
Or, take P. delavayi seed, 30 DEG C of cold pressing temperature, cold pressing pressure 60MPa, cold pressing time 2h.
Embodiment 2:
Malania Oleifera Oil 300g, P. delavayi oil 200g, add Lactose, Microcrystalline Cellulose, starch, hydroxypropyl cellulose etc. auxiliary
Material, prepares wet granular, crosses No. 9 sieves, 30min, granulate is dried, loads in No. 0 capsule shells, make after being repeatedly dried in 60 DEG C of baking ovens
1000, every 500mg, wherein neural acid content is 35.12%.
Malania Oleifera Oil, peony seed oil are obtained by embodiment 1 methods described.
Embodiment 3:
The Malania Oleifera Oil being extracted for investigating the present invention further resists the curative effect of senile dementia, and the present invention is according to choline
Theory can be damaged, measure the anti-acetylcholinesterase activity of different anti senile dementia drugs and Malania Oleifera Oil of the present invention.By body
Outer mensure medicine the suppression ratio of acetylcholinesterase is proved its have functions that the cerebral functional deterioration disease such as anti-senile dementia with
Effect (being shown in Table 1).The present invention develops extraction natural plant Malania Oleifera Oil as one kind safely and efficiently function from malania oleifera
Property food, supplement human brain necessary to functional materials be one of inevitable choice of mankind nowadays brain health.
Table 1 Malania Oleifera Oil, Radix Polygalae total saponins, the suppression ratio to acetylcholinesterase for the huperzine A
Sample ID | Extracting method | Concentration | AchE suppression ratio (%) |
Malania Oleifera Oil | Ultrasonic extraction | 1mg mL-1 | 88.62±0.23 |
Radix Polygalae | Water extraction total saponins | 1mg mL-1 | 72.75±1.13 |
Huperzine A | Street drug | 1mg mL-1 | 93.45±2.08 |
Embodiment 4:
For investigating clinical efficacy and the safety of the present invention further, select 30 curative effects to functional food of the present invention
Carry out clinical observation.The formula therapeutic effect standard of the embodiment of the present invention 1 and 2:Cure:No forgetful, memory recovers normal.Good
Turn:Forgetful obvious mitigation.Do not heal:Forgetful be not improved, memory is no clearly better.Through treatment 30, cure 24, take a turn for the better
4, not more 2, total effective rate 93%.There is no any side effect and untoward reaction.
Embodiment 5:
The confection of suitable middle-aged and elderly people is prepared into for main component with Malania Oleifera Oil and peony seed oil:
Brain-strengthening Sugar Sphere:Malania Oleifera Oil 1-10% and peony seed oil 1-10%, citric acid 0.1 1.0%, vegetable oil 0.1
1.0%, white sugar 20 40%, maltose syrup is supplemented to 100%.Maltose is heated, melts, addition white sugar, vegetable oil,
Adjust acidity and mouthfeel with citric acid, finally with the nervonic acid of vegetable oil dissolving, pour mould into, cooling, obtain final product.
Embodiment 6:
Inventive formulation antioxidation activity in vitro is tested:
By inventive formulation compositionss (Malania Oleifera Oil 60%-75%, peony seed oil 10-20%, purity 80% natural VE
1%-5%, purity 40%DHA algae oil 5%-15%), Malania Oleifera Oil respectively with DPPH (final concentration of 100 μM) hybrid reaction, if
Fixed 3 repeating holes, arrange the not blank of drug containing and Trolox positive control simultaneously, 30 DEG C, 1h, and microplate reader measures OD
Value, Detection wavelength is 515nm.It is calculated antioxygen rate.
Table 10 antioxidation activity in vitro result of the present invention
Claims (10)
1. brain-strengthening antioxidant health-care product, by weight percentage this health product are made up of following components:
Malania Oleifera Oil 60%-75%, peony seed oil 10-20%, purity 80% natural VE 1%-5%, purity 40%DHA algae oil
5%-15%.
2., according to the brain-strengthening antioxidant health-care product described in claim 1, wherein Malania Oleifera Oil is that 70%-75%, peony seed oil are
15-20%, purity 80% natural VE are 1%-3%, purity 40%DHA algae oil is 5%-10%.
3., according to the brain-strengthening antioxidant health-care product described in claim 1 or 2, wherein Malania Oleifera Oil is that 71.1%, peony seed oil is
17%th, purity 80% natural VE be 1.9%, purity 40%DHA algae oil be 10%.
4. the preparation method of the brain-strengthening antioxidant health-care product described in claim 1 is it is characterised in that in described anti-health food
Malania Oleifera Oil be to be prepared by following methods:Take malania oleifera kernel, pulverize, cross 20-40 mesh sieve, high temperature steaming 20-30 divides
Clock, by liquid ratio 1:3-5V:V, g:ML adds edible ethanol, and ultrasonic assistant extracts 30-40min, ultrasonic power 120-
150W, ultrasonic temperature is 30-40 DEG C, supersound extraction 2-3 time, sucking filtration, merging filtrate, in 40-50 DEG C of concentrating under reduced pressure, removes solvent
Obtain Malania Oleifera Oil.
5. the preparation method of the brain-strengthening antioxidant health-care product described in claim 1 is it is characterised in that in described anti-health food
Peony seed oil be to be prepared by following methods:After taking P. delavayi seed screen after naturally drying in the shade, shell, being dried, pulverizing
Cross 60 mesh sieves and obtain P. delavayi seed powder, carry out supercritical carbon dioxide extraction, extraction conditionss are:Extraction time 60min, temperature 40
DEG C, pressure 45MPa, CO2 flow 20kg/h;Or take P. delavayi seed powder to carry out cold pressing, and 30 DEG C of cold pressing temperature, cold pressing pressure 60MPa,
Cold pressing time 2h;Or taking P. delavayi seed powder to carry out surname extraction, Extraction solvent is petroleum ether, screen size 60 mesh, Extracting temperature
70 DEG C, solid-to-liquid ratio is 1:30.
6. the brain-strengthening antioxidant health-care product described in claim 1 or 2 or 3 is preparing anti-senile dementia disease or anti-cerebral functional deterioration disease
Health product in application.
7. application in preparing acetylcholinesteraseinhibitors inhibitors for the brain-strengthening antioxidant health-care product described in claim 1 or 2 or 3.
8. application in preparing functional food for the brain-strengthening antioxidant health-care product described in claim 1 or 2 or 3.
9. according to the brain-strengthening antioxidant health-care product described in claim 1 or 2 or 3 it is characterised in that described peony seed oil former
Shangri-la P. delavayi taken from by material.
10. according to the brain-strengthening antioxidant health-care product described in claim 1 or 2 or 3 it is characterised in that described peony seed oil former
Material takes from P. delavayi and Paeonia ostii Paeonia suffruticosa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610770493.6A CN106376933A (en) | 2016-08-30 | 2016-08-30 | Brain-invigorating antioxidant health product and applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610770493.6A CN106376933A (en) | 2016-08-30 | 2016-08-30 | Brain-invigorating antioxidant health product and applications thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106376933A true CN106376933A (en) | 2017-02-08 |
Family
ID=57938852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610770493.6A Pending CN106376933A (en) | 2016-08-30 | 2016-08-30 | Brain-invigorating antioxidant health product and applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106376933A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107136511A (en) * | 2017-05-25 | 2017-09-08 | 山东省科学院生物研究所 | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof |
CN107156734A (en) * | 2017-05-19 | 2017-09-15 | 舒城圣桂食品有限公司 | A kind of eight treasures (choice ingredients of certain special dishes) wild vegetable |
CN107441130A (en) * | 2017-08-04 | 2017-12-08 | 杨宇明 | A kind of composition of the anti-Alzheimer disease of effective extract containing malania oleifera and its application |
CN116098937A (en) * | 2022-12-02 | 2023-05-12 | 山东省科学院菏泽分院 | Application of peony seed oil in cerebral ischemia reperfusion injury protection |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104258193A (en) * | 2014-10-17 | 2015-01-07 | 云南省林业科学院 | Drug composition for treating neurasthenia and preventing senile dementia |
CN104351358A (en) * | 2014-11-18 | 2015-02-18 | 威海桦众节能设备有限公司 | Brain-enhancing and memory-improving health food |
CN104490774A (en) * | 2014-12-11 | 2015-04-08 | 福州乾正药业有限公司 | Water emulsifier composition containing nervonic acid as well as preparation method and application thereof |
CN104757140A (en) * | 2015-03-17 | 2015-07-08 | 山东西王食品有限公司 | Brain strengthening and intelligence improving blending corn oil |
CN104886272A (en) * | 2014-03-06 | 2015-09-09 | 洛阳春魁农业开发有限公司 | Special dietary peony seed nutritional blend oil for middle-aged and elderly people |
CN105394204A (en) * | 2015-11-09 | 2016-03-16 | 北京同仁堂安徽中药材有限公司 | Blend oil containing acer truncatum seed oil and preparation method of blend oil |
-
2016
- 2016-08-30 CN CN201610770493.6A patent/CN106376933A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104886272A (en) * | 2014-03-06 | 2015-09-09 | 洛阳春魁农业开发有限公司 | Special dietary peony seed nutritional blend oil for middle-aged and elderly people |
CN104258193A (en) * | 2014-10-17 | 2015-01-07 | 云南省林业科学院 | Drug composition for treating neurasthenia and preventing senile dementia |
CN104351358A (en) * | 2014-11-18 | 2015-02-18 | 威海桦众节能设备有限公司 | Brain-enhancing and memory-improving health food |
CN104490774A (en) * | 2014-12-11 | 2015-04-08 | 福州乾正药业有限公司 | Water emulsifier composition containing nervonic acid as well as preparation method and application thereof |
CN104757140A (en) * | 2015-03-17 | 2015-07-08 | 山东西王食品有限公司 | Brain strengthening and intelligence improving blending corn oil |
CN105394204A (en) * | 2015-11-09 | 2016-03-16 | 北京同仁堂安徽中药材有限公司 | Blend oil containing acer truncatum seed oil and preparation method of blend oil |
Non-Patent Citations (5)
Title |
---|
丁俊峰 等: "超声波辅助提取蒜头果果油的工艺研究", 《食品科技》 * |
施蕊 等: "蒜头果种仁油抗氧化活性成分研究", 《西南林业大学学报》 * |
李文保 等: "神经酸及其在预防和治疗脑病中的应用研究进展", 《药学进展》 * |
翟文婷 等: "牡丹籽油成分分析及其抗氧化活性研究", 《烟台大学学报(自然科学与工程版)》 * |
赵能 等: "滇牡丹籽油与凤丹牡丹籽油品质及活性对比研究", 《中国油脂》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107156734A (en) * | 2017-05-19 | 2017-09-15 | 舒城圣桂食品有限公司 | A kind of eight treasures (choice ingredients of certain special dishes) wild vegetable |
CN107136511A (en) * | 2017-05-25 | 2017-09-08 | 山东省科学院生物研究所 | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof |
CN107441130A (en) * | 2017-08-04 | 2017-12-08 | 杨宇明 | A kind of composition of the anti-Alzheimer disease of effective extract containing malania oleifera and its application |
CN116098937A (en) * | 2022-12-02 | 2023-05-12 | 山东省科学院菏泽分院 | Application of peony seed oil in cerebral ischemia reperfusion injury protection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khan et al. | [Retracted] Citrus Genus and Its Waste Utilization: A Review on Health‐Promoting Activities and Industrial Application | |
CN103190504B (en) | Method for processing peony pistil tea | |
CN106376933A (en) | Brain-invigorating antioxidant health product and applications thereof | |
CN103193751A (en) | Method for continuously extracting active ingredients from grape seeds | |
CN101919452B (en) | Compound oil health food | |
CN102696783A (en) | Walnut oil and processing method thereof | |
CN105670778A (en) | Method for extracting peony seed oil from peony seeds | |
Shahrajabian et al. | A short review of goji berry, ginger, ginseng and astragalus in traditional Chinese and Asian medicine | |
CN101658210A (en) | Perilla sesame oil and preparation method as well as application thereof | |
CN111480830A (en) | Enzyme liquid, application and preparation method thereof and anti-aging product | |
Asgari et al. | Survey of the History and Applications of Saffron | |
CN106561843A (en) | Method for preparing peony and sunflower seed oil | |
CN106236667A (en) | A kind of P. delavayi natural skin care product and preparation method thereof | |
CN101717799B (en) | Method for extracting Trichosanthes kirilowii Maxim seed oil | |
CN105819967A (en) | Nutrient rich in selenium and iodine, preparing method thereof and method for cultivating tomato rich in selenium and iodine | |
CN101643403A (en) | Method for extracting linolenic acid from purslane | |
CN107468614A (en) | Breast beautifying composition, breast beautifying liquid and preparation method thereof | |
CN104126678A (en) | Good-flavored plant blend oil rich in omega-3 polyunsaturated fatty acids and production method thereof | |
CN106106859A (en) | A kind of Flos Chrysanthemi Fragrance Hill Oleum Camelliae and preparation method thereof | |
CN105802726A (en) | Health-care peony seed oil and preparation method thereof | |
CN109511678A (en) | A kind of interplanting method of Rosa roxburghii Tratt and the bletilla striata | |
CN101485715A (en) | Soft capsule for resisting oxidation and delaying aging and preparation method thereof | |
CN106433949A (en) | Low-acid-value Yunnan pine seed oil, preparation method and application thereof | |
CN105878118A (en) | Method for extracting cedrela sinensis extract from cedrela sinensis leaves and application of method | |
IT202000012466A1 (en) | METHOD FOR THE PRODUCTION OF TRITERPENIC ACIDS BY IN VITRO CULTURE OF CORNS DERIVING FROM APPLE PULP RED SENTINEL (RS) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Qiu Inventor after: Liu Xiangyi Inventor after: Shi Rui Inventor before: Yang Yuming Inventor before: Wang Juan Inventor before: Liu Xiangyi Inventor before: Shi Rui Inventor before: Chen Qiu |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170208 |